1. The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation
- Author
-
de Lima, Mikhael Haruo Fernandes, Machado, Caio Cavalcante, Nascimento, Daniele Carvalho, Silva, Camila Meirelles S, Toller-Kawahisa, Juliana Escher, Rodrigues, Tamara Silva, Veras, Flavio Protassio, Pontelli, Marjorie Cornejo, Castro, Italo A, Zamboni, Dario Simões, Filho, José-Carlos A, Cunha, Thiago M, Arruda, Eurico, da Cunha, Larissa Dias, Oliveira, Renê DR, Cunha, Fernando Q, and Louzada-Junior, Paulo
- Abstract
Abstract: The TIGIT+FOXP3+Treg subset (TIGIT+Tregs) exerts robust suppressive activity on cellular immunity and predisposes septic individuals to opportunistic infection. We hypothesized that TIGIT+Tregs could play an important role in intensifying the COVID-19 severity and hampering the defense against nosocomial infections during hospitalization. Herein we aimed to verify the association between the levels of the TIGIT+Tregs with the mechanical ventilation requirement, fatal outcome, and bacteremia during hospitalization. TIGIT+Tregs were immunophenotyped by flow cytometry from the peripheral blood of 72 unvaccinated hospitalized COVID-19 patients at admission from May 29th to August 6th, 2020. The patients were stratified during hospitalization according to their mechanical ventilation requirement and fatal outcome. COVID-19 resulted in a high prevalence of the TIGIT+Tregs at admission, which progressively increased in patients with mechanical ventilation needs and fatal outcomes. The prevalence of TIGIT+Tregs positively correlated with poor pulmonary function and higher plasma levels of LDH, HMGB1, FGL2, and TNF. The non-survivors presented higher plasma levels of IL-33, HMGB1, FGL2, IL-10, IL-6, and 5.54 times more bacteremia than survivors. Conclusions: The expansion of the TIGIT+Tregs in COVID-19 patients was associated with inflammation, lung dysfunction, bacteremia, and fatal outcome.
- Published
- 2023